79 related articles for article (PubMed ID: 20236690)
21. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms.
Zhang W; Hart J; McLeod HL; Wang HL
Am J Clin Pathol; 2005 Jul; 124(1):11-9. PubMed ID: 15923159
[TBL] [Abstract][Full Text] [Related]
24. A novel gene containing PDZ and LIM domains, PCD1, is overexpressed in human colorectal cancer.
Furuya M; Tsuji N; Endoh T; Moriai R; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2002; 22(6C):4183-6. PubMed ID: 12553053
[TBL] [Abstract][Full Text] [Related]
25. Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas.
Ishiguro K; Yoshida T; Yagishita H; Numata Y; Okayasu T
Gut; 2006 May; 55(5):695-702. PubMed ID: 16354798
[TBL] [Abstract][Full Text] [Related]
26. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of activator protein-4 in human colorectal cancer with metastasis.
Cao J; Tang M; Li WL; Xie J; Du H; Tang WB; Wang H; Chen XW; Xiao H; Li Y
Int J Surg Pathol; 2009 Feb; 17(1):16-21. PubMed ID: 18480385
[TBL] [Abstract][Full Text] [Related]
29. JK1 (FAM134B) gene and colorectal cancer: a pilot study on the gene copy number alterations and correlations with clinicopathological parameters.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Mol Pathol; 2014 Aug; 97(1):31-6. PubMed ID: 24825067
[TBL] [Abstract][Full Text] [Related]
30. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
31. GAEC1 drives colon cancer progression.
Lee KT; Vider J; Tang JC; Gopalan V; Lam AK
Mol Carcinog; 2019 Jul; 58(7):1145-1154. PubMed ID: 30825264
[TBL] [Abstract][Full Text] [Related]
32. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
Tada T; Watanabe T; Kazama S; Kanazawa T; Hata K; Komuro Y; Nagawa H
Hepatogastroenterology; 2003; 50(54):1756-60. PubMed ID: 14696398
[TBL] [Abstract][Full Text] [Related]
33. [Immunohistochemical expression of p53 oncoprotein in large bowel adenomas and carcinomas].
Roa JC; Villaseca MA; Roa I; Araya JC; Okayasu I; Flores P; Flores M
Rev Med Chil; 1997 May; 125(5):523-9. PubMed ID: 9497572
[TBL] [Abstract][Full Text] [Related]
34. Copy number increase of aurora kinase A in colorectal cancers: a correlation with tumor progression.
Zhang C; Fang Z; Xiong Y; Li J; Liu L; Li M; Zhang W; Wan J
Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):834-8. PubMed ID: 20929925
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of BRCA1, BRCA2 and Hmsh2 mRNA expression in colorectal Lieberkühnien adenocarcinomas and matched normal mucosa: relationship with cellular proliferation.
Le Corre L; Vissac-Sabatier C; Chalabi N; Bignon YJ; Daver A; Chassevent A; Bernard-Gallon DJ
Anticancer Res; 2005; 25(3B):2009-16. PubMed ID: 16158938
[TBL] [Abstract][Full Text] [Related]
36. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas.
Minamoto T; Sawaguchi K; Mai M; Yamashita N; Sugimura T; Esumi H
Cancer Res; 1994 Jun; 54(11):2841-4. PubMed ID: 8187064
[TBL] [Abstract][Full Text] [Related]
37. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors.
Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Murai Y; Nomoto K; Takano Y
Anticancer Res; 2007; 27(1A):259-65. PubMed ID: 17352241
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of the Interferon regulatory factor 4-binding protein in human colorectal cancer and its clinical significance.
Zhang Z; Wang Q; Li P; Zhou Y; Li S; Yi W; Chen A; Kong P; Hu C
Cancer Epidemiol; 2009 Aug; 33(2):130-6. PubMed ID: 19679060
[TBL] [Abstract][Full Text] [Related]
39. Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma.
Shivapurkar N; Maitra A; Milchgrub S; Gazdar AF
Hum Pathol; 2001 Feb; 32(2):169-77. PubMed ID: 11230704
[TBL] [Abstract][Full Text] [Related]
40. LRIG1 expression in colorectal cancer.
Ljuslinder I; Golovleva I; Palmqvist R; Oberg A; Stenling R; Jonsson Y; Hedman H; Henriksson R; Malmer B
Acta Oncol; 2007; 46(8):1118-22. PubMed ID: 17851870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
